Effect of Troponin I Ser23/24 Phosphorylation on Ca2+-sensitivity in Human Myocardium Depends on the Phosphorylation Background

Overview

Journal J Mol Cell Cardiol

Specialty Cardiology & Vascular Diseases

Date 2010 Jan 19

PMID 20079747

Citations 46

Authors

Viola Kooij

Martina Saes

Kornelia Jaquet

Ruud Zaremba

D Brian Foster

Anne M Murphy

Cris Dos Remedios

Jolanda van der Velden

Ger J M Stienen

Affiliations

Soon will be listed here.

Abstract

Protein kinase A (PKA)-mediated phosphorylation of Ser23/24 of cardiac troponin I (cTnI) causes a reduction in Ca(2+)-sensitivity of force development. This study aimed to determine whether the PKA-induced modulation of the Ca(2+)-sensitivity is solely due to cTnI phosphorylation or depends on the phosphorylation status of other sarcomeric proteins. Endogenous troponin (cTn) complex in donor cardiomyocytes was partially exchanged (up to 66+/-1%) with recombinant unphosphorylated human cTn and in failing cells similar exchange was achieved using PKA-(bis)phosphorylated cTn complex. Cardiomyocytes immersed in exchange solution without complex added served as controls. Partial exchange of unphosphorylated cTn complex in donor tissue significantly increased Ca(2+)-sensitivity (pCa(50)) to 5.50+/-0.02 relative to the donor control value (pCa(50)=5.43+/-0.04). Exchange in failing tissue with PKA-phosphorylated cTn complex did not change Ca(2+)-sensitivity relative to the failing control (pCa(50)=5.60+/-0.02). Subsequent treatment of the cardiomyocytes with the catalytic subunit of PKA significantly decreased Ca(2+)-sensitivity in donor and failing tissue. Analysis of phosphorylated cTnI species revealed the same distribution of un-, mono- and bis-phosphorylated cTnI in donor control and in failing tissue exchanged with PKA-phosphorylated cTn complex. Phosphorylation of myosin-binding protein-C in failing tissue was significantly lower compared to donor tissue. These differences in Ca(2+)-sensitivity in donor and failing cells, despite similar distribution of cTnI species, could be abolished by subsequent PKA-treatment and indicate that other targets of PKA are involved the reduction of Ca(2+)-sensitivity. Our findings suggest that the sarcomeric phosphorylation background, which is altered in cardiac disease, influences the impact of cTnI Ser23/24 phosphorylation by PKA on Ca(2+)-sensitivity.

Citing Articles

Mechanism-based myofilament manipulation to treat diastolic dysfunction in HFpEF.

Dominic K, Schmidt A, Granzier H, Campbell K, Stelzer J Front Physiol. 2024; 15:1512550.

PMID: 39726859 PMC: 11669688. DOI: 10.3389/fphys.2024.1512550.

Thin filament regulation of cardiac muscle power output: Implications for targets to improve human failing hearts.

Hanft L, Robinett J, Kalogeris T, Campbell K, Biesiadecki B, McDonald K J Gen Physiol. 2023; 155(5).

PMID: 37000170 PMC: 10067705. DOI: 10.1085/jgp.202213290.

The lack of Troponin I Ser-23/24 phosphorylation is detrimental to in vivo cardiac function and exacerbates cardiac disease.

Salhi H, Shettigar V, Salyer L, Sturgill S, Brundage E, Robinett J J Mol Cell Cardiol. 2023; 176:84-96.

PMID: 36724829 PMC: 10074981. DOI: 10.1016/j.yjmcc.2023.01.010.

Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.

Gomori K, Herwig M, Budde H, Hassoun R, Mostafi N, Zhazykbayeva S ESC Heart Fail. 2022; 9(4):2585-2600.

PMID: 35584900 PMC: 9288768. DOI: 10.1002/ehf2.13973.

Integrated Quantitative Phosphoproteomics and Cell-based Functional Screening Reveals Specific Pathological Cardiac Hypertrophy-related Phosphorylation Sites.

Kwon H, Choi H, Park S, Park W, Kim D, Park Z Mol Cells. 2021; 44(7):500-516.

PMID: 34158421 PMC: 8334354. DOI: 10.14348/molcells.2021.4002.

References

Kruger M, Linke W . Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil. 2006; 27(5-7):435-44. DOI: 10.1007/s10974-006-9090-5. View

Neumann J, Eschenhagen T, Jones L, Linck B, Schmitz W, Scholz H . Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol. 1997; 29(1):265-72. DOI: 10.1006/jmcc.1996.0271. View

van Heerebeek L, Borbely A, Niessen H, Bronzwaer J, van der Velden J, Stienen G . Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006; 113(16):1966-73. DOI: 10.1161/CIRCULATIONAHA.105.587519. View

Bodor G, Oakeley A, Allen P, Crimmins D, Ladenson J, Anderson P . Troponin I phosphorylation in the normal and failing adult human heart. Circulation. 1997; 96(5):1495-500. DOI: 10.1161/01.cir.96.5.1495. View

Walker L, Walker J, Ambler S, Buttrick P . Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice. J Mol Cell Cardiol. 2009; 48(6):1180-6. PMC: 4447307. DOI: 10.1016/j.yjmcc.2009.09.010. View

Kooij V, Boontje N, Zaremba R, Jaquet K, Dos Remedios C, Stienen G . Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardium. Basic Res Cardiol. 2009; 105(2):289-300. PMC: 2807945. DOI: 10.1007/s00395-009-0053-z. View

Borbely A, van der Velden J, Papp Z, Bronzwaer J, Edes I, Stienen G . Cardiomyocyte stiffness in diastolic heart failure. Circulation. 2005; 111(6):774-81. DOI: 10.1161/01.CIR.0000155257.33485.6D. View

Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H . Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res. 2002; 90(11):1181-8. DOI: 10.1161/01.res.0000021115.24712.99. View

El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh Y, Nattel S . Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol. 2007; 43(2):223-9. DOI: 10.1016/j.yjmcc.2007.05.003. View

10.

Yasuda S, Coutu P, Sadayappan S, Robbins J, Metzger J . Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes. Circ Res. 2007; 101(4):377-86. DOI: 10.1161/CIRCRESAHA.106.145557. View

11.

Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M . PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res. 2009; 105(7):631-8, 17 p following 638. PMC: 2764991. DOI: 10.1161/CIRCRESAHA.109.198465. View

12.

Zhang R, Zhao J, Potter J . Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C. J Biol Chem. 1995; 270(51):30773-80. DOI: 10.1074/jbc.270.51.30773. View

13.

Hamdani N, Kooij V, Van Dijk S, Merkus D, Paulus W, Dos Remedios C . Sarcomeric dysfunction in heart failure. Cardiovasc Res. 2007; 77(4):649-58. DOI: 10.1093/cvr/cvm079. View

14.

Kirchhefer U, Schmitz W, Scholz H, Neumann J . Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res. 1999; 42(1):254-61. DOI: 10.1016/s0008-6363(98)00296-x. View

15.

Braz J, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R . PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004; 10(3):248-54. DOI: 10.1038/nm1000. View

16.

Velden J, Klein L, van der Bijl M, Huybregts M, Stooker W, WITKOP J . Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. Cardiovasc Res. 1998; 38(2):414-23. DOI: 10.1016/s0008-6363(98)00019-4. View

17.

Brodde O, Michel M . Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev. 1999; 51(4):651-90. View

18.

Mittmann K, Jaquet K, Heilmeyer Jr L . Ordered phosphorylation of a duplicated minimal recognition motif for cAMP-dependent protein kinase present in cardiac troponin I. FEBS Lett. 1992; 302(2):133-7. DOI: 10.1016/0014-5793(92)80423-e. View

19.

Bowling N, Walsh R, Song G, Estridge T, Sandusky G, Fouts R . Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation. 1999; 99(3):384-91. DOI: 10.1161/01.cir.99.3.384. View

20.

LeWinter M, Wu Y, Labeit S, Granzier H . Cardiac titin: structure, functions and role in disease. Clin Chim Acta. 2006; 375(1-2):1-9. DOI: 10.1016/j.cca.2006.06.035. View